Results 181 to 190 of about 10,461,040 (280)

The field factor: Industry publishing contribution and novelty in science. [PDF]

PLoS One
Shokhand A, Kaushik N, Mukherjee S.
europepmc   +1 more source

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

Molecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang, Ayesha Alvero, Yi Qin, Mingjin Wang, Alexandra Fox, Yanfeng Li, Michael Millman, Amy Kemper, Gil Mor, Xian Shuang Liu, Michael Chopp, Zheng Gang Zhang, Yi Zhang   +12 more
wiley   +1 more source

Publishing Without Borders: Advancing Equity in Scientific Authorship. [PDF]

Cureus
Tanwar S, Kumar A.
europepmc   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

Speed, Innovation, and Trust: Guiding Scientific Publishing in the Age of Artificial Intelligence. [PDF]

Cureus
Muacevic A.
europepmc   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Overcoming high-temperature performance limitations: Multidimensional design and innovation of thin-film thermocouples. [PDF]

iScience
Zhang Z, Zhang T, Liu Z, Wang M, Zhou G, Liu X, Wu C, Fang X, Duan D, Tian B.   +9 more
europepmc   +1 more source

To publish or not to publish?

Annals of Tropical Medicine and Public Health, 2012
openaire   +1 more source

A decade of impact: The reach, influence, and evolution of the Journal of Community Safety and Well-Being

Journal of Community Safety and Well-Being
SG Publishing Inc.
doaj   +1 more source

Expanding equity horizons in knowledge sharing: How can global health journals level up? [PDF]

Int J Public Health
Bandara S, Sant Fruchtman C, Joubert N, Zinsstag L, Banerjee A, Beaulieu IM, Tetui M, Qiang V.   +7 more
europepmc   +1 more source